Skip to content
Basilard BioTech Basilard BioTech
  • Home
  • About Us
    • Our People
    • Our History
  • Our Technology
    • Deterministic Mechanoporation (DMP) Gene Delivery Platform
  • Newsroom
    • Press Releases
    • Media
    • Publications
  • Investors
  • Employment Opportunities
  • Contact Us
  • March 30, 2023

Building successful nanomedicine start-ups (Nature Nanotechnology, August 2022)

Two comments analyse the aspects that allowed four nanomedicine start-ups to overcome the biotech valley of death and build timely…

  • August 10, 2022

Basilard BioTech mentioned in Nature Technology (June 2022) as one of a few companies at the forefront of nanoneedle technology

Nanotechnology has matured to the point where it provides exquisite solutions to key challenges across medicine and biology, as seen…

  • August 10, 2022

Founder Focus: Brynley Lee, CEO & Founder of Basilard BioTech (Sunstone, September 2022)

The story of Basilard BioTech (part of the Sunstone Management investment portfolio) could be the blueprint for taking an invention…

  • February 20, 2020

Massively-Parallelized, Deterministic Mechanoporation for Intracellular Delivery (Published on ACS Publications)

We recently published data in NanoLetters. It details how, when transfecting primary human T cells with a standard GFP plasmid,…

  • Follow Us

Stay informed and healthy

© Copyright Basilard BioTech 2024. All Right Reserved. Designed and Developed by Nanobot Medical Animation Studio